Literature DB >> 26295280

Treatment of norovirus particles with citrate.

Anna D Koromyslova1, Peter A White2, Grant S Hansman3.   

Abstract

Human norovirus is a dominant cause of acute gastroenteritis around the world. Several norovirus disinfectants label citric acid as an active ingredient. In this study, we showed that norovirus virus-like particles (VLPs) treated with citrate buffer caused the particles to alter their morphology, including increased diameters associated with a new ring-like structure. We also found that epitopes on the protruding (P) domain on these particles were more readily accessible to antibodies after the citrate treatment. These results suggested that citrate had a direct effect on the norovirus particles. Using X-ray crystallography, we showed that the P domain bound citrate from lemon juice and a disinfectant containing citric acid. Importantly, citrate binds at the histo-blood group antigen binding pocket, which are attachment factors for norovirus infections. Taken together, these new findings suggested that it might be possible to treat/reduce norovirus infections with citrate, although further studies are needed.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Disinfectant; Norovirus; Virus-like particles; X-ray structure

Mesh:

Substances:

Year:  2015        PMID: 26295280     DOI: 10.1016/j.virol.2015.07.009

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  Nanobody-Mediated Neutralization Reveals an Achilles Heel for Norovirus.

Authors:  Anna D Koromyslova; Jessica M Devant; Turgay Kilic; Charles D Sabin; Virginie Malak; Grant S Hansman
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  Efficacy of Silver Dihydrogen Citrate and Steam Vapor against a Human Norovirus Surrogate, Feline Calicivirus, in Suspension, on Glass, and on Carpet.

Authors:  David Buckley; Muthu Dharmasena; Angela Fraser; Charles Pettigrew; Jeffery Anderson; Xiuping Jiang
Journal:  Appl Environ Microbiol       Date:  2018-05-31       Impact factor: 4.792

Review 3.  Human Norovirus Interactions with Histo-Blood Group Antigens and Human Milk Oligosaccharides.

Authors:  Horst Schroten; Franz-Georg Hanisch; Grant S Hansman
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

Review 4.  Norovirus Binding to Ligands Beyond Histo-Blood Group Antigens.

Authors:  Erin A Almand; Matthew D Moore; Lee-Ann Jaykus
Journal:  Front Microbiol       Date:  2017-12-21       Impact factor: 5.640

Review 5.  Citric acid: emerging applications of key biotechnology industrial product.

Authors:  Rosaria Ciriminna; Francesco Meneguzzo; Riccardo Delisi; Mario Pagliaro
Journal:  Chem Cent J       Date:  2017-03-08       Impact factor: 4.215

6.  Dynamic rotation of the protruding domain enhances the infectivity of norovirus.

Authors:  Chihong Song; Reiko Takai-Todaka; Motohiro Miki; Kei Haga; Akira Fujimoto; Ryoka Ishiyama; Kazuki Oikawa; Masaru Yokoyama; Naoyuki Miyazaki; Kenji Iwasaki; Kosuke Murakami; Kazuhiko Katayama; Kazuyoshi Murata
Journal:  PLoS Pathog       Date:  2020-07-02       Impact factor: 6.823

Review 7.  Norovirus antivirals: Where are we now?

Authors:  Natalie E Netzler; Daniel Enosi Tuipulotu; Peter A White
Journal:  Med Res Rev       Date:  2018-12-25       Impact factor: 12.944

8.  Chemical-Shift Perturbations Reflect Bile Acid Binding to Norovirus Coat Protein: Recognition Comes in Different Flavors.

Authors:  Robert Creutznacher; Eric Schulze; Georg Wallmann; Thomas Peters; Matthias Stein; Alvaro Mallagaray
Journal:  Chembiochem       Date:  2019-12-05       Impact factor: 3.164

9.  Inhibitory Effects of Laminaria japonica Fucoidans Against Noroviruses.

Authors:  Hyojin Kim; Chae Yeon Lim; Dan Bi Lee; Jong Hyeon Seok; Kyung Hyun Kim; Mi Sook Chung
Journal:  Viruses       Date:  2020-09-07       Impact factor: 5.048

10.  Structural Basis of Nanobodies Targeting the Prototype Norovirus.

Authors:  Kerstin Ruoff; Turgay Kilic; Jessica Devant; Anna Koromyslova; Alessa Ringel; Alexander Hempelmann; Celina Geiss; Juliane Graf; Michelle Haas; Imme Roggenbach; Grant Hansman
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.